Overall, people with type 2 diabetes and hospitalization more often received insulin‐based regimens (either monotherapy or insulin combined with one glucose‐lowering drug) (55%) than did comparisons (45%). The gene discussed is INS; the disease is type 2 diabetes mellitus.